Reasons Why Bruker Corporation (BRKR) Appears So Attractive

Bruker Corporation (NASDAQ:BRKR) is one of the 10 best life sciences stocks to buy according to hedge funds.

On February 13, Jefferies analyst Tycho Peterson reduced the firm’s price target on Bruker Corporation (NASDAQ:BRKR) from $55 to $50. The analyst maintained his Buy rating on the shares with an upside potential of almost 31%.

Peterson noted that the fourth quarter marked an end to a difficult year for the company, largely driven by soft U.S. A&G demand. For 2026, he expects improving conditions, though he does not anticipate a sharp rebound. He added that the first quarter expectations have recently been lowered, but not by too much. This leads to a heavier reliance on a strong second-half recovery to meet full-year expectations.

On February 13, BofA analyst Michael Ryskin reduced the firm’s price target on Bruker Corporation (NASDAQ:BRKR) from $60 to $49. The analyst maintained a Buy rating on the shares with an upside potential of 28%.

Ryskin mentioned that FY26 targets remain in line with or slightly ahead of consensus. However, a fourth-quarter margins miss, and the need for a sharp performance ramp through 2026 is keeping investors cautious. While the analyst remains constructive on the company’s outlook, he lowered its valuation multiple on the 2027 EBTIDA estimate, citing multiple compression across peers.

Bruker Corporation (NASDAQ:BRKR) is involved in the development and distribution of high-performance scientific instruments and analytical and diagnostic solutions. Their offerings are useful in pharmaceutical and molecular research, biotechnology, and materials analysis. It functions through 4 distinct segments, i.e., BSI BioSpin, BSI Nano, BSI CALID, and Bruker Energy & Supercon Technologies (BEST).

While we acknowledge the potential of BRKR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.

Disclosure: None. Follow Insider Monkey on Google News.